SCHEMBL8962380

SCHEMBL8962380

CC(C)c1cccc(C(C)C)c1NS(=O)(=O)CC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8962531 0.87 SMN1; SMN2 (0.47) LMNAKMT2ASMN1; SMN2
SCHEMBL8962536 0.86 SOAT1 (0.44) LMNAKMT2ASMN1; SMN2
SCHEMBL9390816 0.86 SMN1; SMN2 (0.50) LMNAKMT2ASMN1; SMN2
SCHEMBL8962535 0.84 SMN1; SMN2 (0.60) LMNAKMT2ASMN1; SMN2
SCHEMBL8962404 0.83 FABP3 (0.46)
SCHEMBL8962425 0.81 SMN1; SMN2 (0.42) SMN1; SMN2
SCHEMBL8962550 0.81 NLRP3 (0.58)
SCHEMBL8962577 0.81 TSHR (0.46) LMNAKMT2ASMN1; SMN2
SCHEMBL8962491 0.79 KMT2A (0.58) LMNAKMT2ASMN1; SMN2
SCHEMBL9059980 0.78 LMNA (0.45) LMNAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996019446-A1 β-CARBOXY SULFONAMIDE ACAT INHIBITORS WARNER-LAMBERT COMPANY (US) 1996-06-27 WO claimed
WO-1996019446-A1 β-CARBOXY SULFONAMIDE ACAT INHIBITORS WARNER-LAMBERT COMPANY (US) 1996-06-27 WO disclosed
US-5491170-A TREATMENT OF HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-02-13 US disclosed
US-5239082-A Sulfonamide tetrazole ACAT inhibitors WARNER-LAMBERT COMPANY (US) 1993-08-24 US disclosed